Polymer Drugs in the Clinical Stage Advantages and Prospects - Maeda, Hiroshi; Kabanov, Alexander; Kataoka, Kazunori; Okano, Teruo; SpringerLink (Online service) (New York, NY : Springer US : Imprint: Springer, 2003)
Challenges in Polymer Therapeutics -- Factors and Mechanism of "EPR" Effect and the Enhanced Antitumor Effects of Macromolecular Drugs Including SMANCS -- PEG-Adenosine Deaminase and PEG-Asparaginase -- Peginterferon alfa-2a (40KD): A Potent Long-Acting Form of Interferon alfa-2a for the Treatment of Hepatitis C -- PEG-Methioninase -- Poly-(L)-Glutamic Acid-Paclitaxel (CT-2103) [XYOTAX™], a Biodegradable Polymeric Drug Conjugate -- HPMA Copolymer Delivery of Chemotherapy and Photodynamic Therapy in Ovarian Cancer -- Drug-HPMA-HuIg Conjugates Effective Against Human Solid Cancer -- CM-Dextran-Polyalcohol-Camptothecin Conjugate -- Polymeric Micelle Drug Carrier Systems: PEG-PAsp(Dox) and Second Generation of Micellar Drugs -- An Interim Analysis of Phase I Clinical Trial of MCC-465, a Doxorubicin (DXR) Encapsulated in PEG-immunoliposome, in Patients with Metastatic Stomach Cancer -- Polymer Conjugates for Imaging -- S-Nitrosylated Polyethylene Glycol-conjugated Hemoglobin Derivative as a Candidate Material for Oxygen Therapeutics.
Keywords: Pharmacology; Polymers .; Medical biochemistry; Oncology .; Pharmacy; Pharmacology/Toxicology.; Polymer Sciences; Medical Biochemistry; Oncology; Pharmacy